CURA and ERIC hosted a web briefing on March 31, 2020, for policymakers and journalists around the country to learn more about biosimilars—complex medications similar to existing biologic medications that create competition and drive savings in the prescription drug marketplace. The briefing presented new research from ERIC and the Johns Hopkins Bloomberg School of Public…
